Nasal insulin may unlock brain secrets in psychosis
NCT ID NCT07252752
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study looks at how insulin given through the nose changes brain signals in people having their first episode of psychosis compared to healthy volunteers. Researchers will use brain scans to measure dopamine activity and energy-related chemicals. The goal is to understand the link between mental health and metabolism, not to provide treatment. About 46 people aged 18-40 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIRST EPISODE PSYCHOSIS (FEP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Vienna
Vienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.